JW Holdings Corporation (096760.KS)
ValueMarkers Composite Index
82% below intrinsic value ($16)
JW Holdings Corporation (096760.KS) — VMCI valuation read
JW Holdings Corporation sits at VMCI 66/100, with the Healthcare sector median at 50. That 16-point spread is the first thing to note on 096760.KS: it tells the reader the composite is favorable before any single ratio is examined, and the mid-cap tier sets the comparison set.
Form 4 disclosures on 096760.KS are blank for the trailing 30 days. With the insider channel offline, the EV/EBITDA delta, free-cash-flow trajectory, and the next earnings print do the talking.
**Investor frame.** The Value read on 096760.KS: 096760.KS trades at 14.0x earnings, 22% below the Healthcare median of 18.0x, with EV/EBITDA at 13.0x against 12.0x. The Quality read: ROIC of 8.0% trails the Healthcare median (10.0%) by 2.0pp. The Risk read: net debt to EBITDA of -1.6x leaves covenant headroom, anchoring the bear scenario on a measurable balance-sheet metric.
096760.KS fell 1.8% over the trailing 7 days, with a -1.1% read on a 30-day basis.
JW Holdings Corporation, together with its subsidiaries, manufactures and sells medicines and medical devices in South Korea and internationally. It offers ETC products, consumer healthcare OTC products, and IV solutions machinery systems. The company also exports its products. JW Holdings Corporation was founded in 1945 and is based in Seoul, South Korea.
Related Stocks in Healthcare
Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.